RHOJ and neoplasm: The following problems remain to be further studied whether RHOJ-mediated signaling devotes to developing anti-tumor immunity in GC cells and whether the combination of small molecule compounds targeting RHOJ and immunosuppressants can improve the prognosis of GC patients.